Related Experiment Video
Updated: Nov 29, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Prevalence, Location, and Determinants of Valvular Calcifications in Congolese Patients on Chronic Hemodialysis: A
Yannick M Engole1, Yves N Lubenga2, Yannick M Nlandu1
1Nephrology Unit, University Hospital of Kinshasa, Kinshasa, Democratic Republic of Congo.
Insights
Valvular calcifications are common in Congolese hemodialysis patients. Hypertension, older age, smoking, and high phosphorus levels are key risk factors for this cardiovascular complication.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Valvular calcifications (VCs) are a significant cardiovascular complication in patients undergoing chronic hemodialysis (HD).
- VCs contribute to increased morbidity and mortality in this vulnerable population.
- Understanding the prevalence and risk factors of VCs in specific demographics, like Congolese HD patients, is crucial.
Purpose of the Study:
- To determine the prevalence and location of valvular calcifications (VCs) in Congolese patients on chronic hemodialysis (HD).
- To identify traditional and chronic kidney disease-specific risk factors associated with VCs in this patient group.
- To provide insights into cardiovascular health management for HD patients in Kinshasa.
Main Methods:
- An observational study was conducted across three HD centers in Kinshasa from March to August 2016.
- Sixty adult patients on maintenance HD for at least six months were recruited.
- Valvular calcifications were diagnosed via echocardiography, and risk factors were analyzed using multivariate analysis.
Main Results:
- Valvular calcifications were present in 38% of the studied patients.
- The most common locations for VCs were the aortic valve (64%) and mitral valve (23%).
- Independent risk factors identified included hypertension, age over 60, tobacco use, and hyperphosphatemia.
Conclusions:
- Valvular calcifications are a frequent finding in Congolese chronic HD patients, even at a relatively young age.
- The study highlights the association of VCs with both traditional cardiovascular risk factors and chronic kidney disease-specific factors like hyperphosphatemia.
- These findings underscore the need for targeted screening and management of VCs in HD populations in sub-Saharan Africa.
Abstract:
Valvular calcifications (VCs) are one of the major cardiovascular complications in patients on chronic hemodialysis (HD) due to its prevalence and predictive morbidity and mortality. The current study assessed the prevalence, location, and risk factors of VC among chronic HD Congolese patients in Kinshasa. This observational study involved three HD centers in Kinshasa between March and August 2016. Consecutive consenting adults on maintenance HD for at least six months were recruited. VCs were defined as a luminous echo on one or more cusps of the aortic or mitral valve. Risk factors of VC were determined by multivariate analysis. Sixty patients (mean age: 52.5 ± 15.9 years) were enrolled. The mean serum calcium and phosphorus were7.9 ± 1.3 mg/dL and 5.7 ± 1.7 mg/dL, respectively. VCs were encountered in 38% of the whole group in aortic and mitral valvular location in 64% and 23%, respectively. Hypertension, age >60 years, tobacco use, and hyperphosphatemia were independently associated with VC. Despite a young age of patients, VCs were a common finding and associated with both traditional and chronic kidney disease-specific risk factors.
More Related Videos
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease II: Clinical Manifestations
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Urinary Tract Calculi I: Introduction